Instylla announces enrollment of initial patient in the prospective multicenter "HALT" Study
The HALT Study at MemorialCare Long Beach Medical Center is intended for the treatment of peripheral arterial bleeds.
Source: oc-breeze.com
📰 Solid Organs News
Solid Organs News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Solid Organs. Real-time updates on events, politics, business and more.
Instylla Announces Enrollment of Initial Patient in the Prospective Multicenter "HALT" Study
/PRNewswire/ -- Instylla, Inc., a privately held company developing next-generation liquid embolics for peripheral vascular embolotherapy, today announced the...
Source: prnewswire.com